Literature DB >> 23321618

The population prevalence of Down's syndrome in England and Wales in 2011.

Jianhua Wu1, Joan K Morris.   

Abstract

There is uncertainty over the population prevalence of people with Down's syndrome in England and Wales. This study aimed to estimate the population prevalence of Down's syndrome in England and Wales in 2011. A meta-analysis of published survival rates of people with Down's syndrome from 1938 to 2010 was conducted and the results were applied to the estimated numbers of babies born with Down's syndrome since 1938 in England and Wales. An estimated 37 090 people had Down's syndrome in England and Wales in 2011, a population prevalence of 0.66 per 1000 people; 650 under 1, 2673 aged 1-5, 7115 aged 5-18, 12819 aged 19-40, 10 626 aged 41-55 and 3207 aged 56 and older. The average life expectancy for babies with Down's syndrome born in 2011 was 51 years and the median life expectancy was 58 years. This study provides clarity on the number of people with Down's syndrome in England and Wales. Owing to sudden increases in the survival of babies with Down's syndrome in the 1950s there are a large proportion of people with Down's syndrome who are in their 40s. These people have an increased risk of developing dementia in the future and services should be aware of their potential needs.

Entities:  

Mesh:

Year:  2013        PMID: 23321618      PMCID: PMC3746270          DOI: 10.1038/ejhg.2012.294

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  Revised estimates of the maternal age specific live birth prevalence of Down's syndrome.

Authors:  J K Morris; D E Mutton; E Alberman
Journal:  J Med Screen       Date:  2002       Impact factor: 2.136

2.  Results of first year (1989) of a national register of Down's syndrome in England and Wales.

Authors:  D E Mutton; E Alberman; R Ide; M Bobrow
Journal:  BMJ       Date:  1991-11-23

3.  Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome.

Authors:  A J Holland; J Hon; F A Huppert; F Stevens; P Watson
Journal:  Br J Psychiatry       Date:  1998-06       Impact factor: 9.319

4.  Life expectancy in Down syndrome adults.

Authors:  P A Baird; A D Sadovnick
Journal:  Lancet       Date:  1988-12-10       Impact factor: 79.321

5.  Mortality and survival of the Down's syndrome population in Western Australia.

Authors:  Q Malone
Journal:  J Ment Defic Res       Date:  1988-02

6.  The changing survival profile of people with Down's syndrome: implications for genetic counselling.

Authors:  E J Glasson; S G Sullivan; R Hussain; B A Petterson; P D Montgomery; A H Bittles
Journal:  Clin Genet       Date:  2002-11       Impact factor: 4.438

7.  Mortality and causes of death in persons with Down syndrome in California.

Authors:  Steven M Day; David J Strauss; Robert M Shavelle; Robert J Reynolds
Journal:  Dev Med Child Neurol       Date:  2005-03       Impact factor: 5.449

8.  Congenital anomaly surveillance in England--ascertainment deficiencies in the national system.

Authors:  P A Boyd; B Armstrong; H Dolk; B Botting; S Pattenden; L Abramsky; J Rankin; M Vrijheid; D Wellesley
Journal:  BMJ       Date:  2004-11-23

9.  Life expectancy in Down syndrome.

Authors:  P A Baird; A D Sadovnick
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

10.  Mortality and life expectancy of Down's syndrome in Denmark.

Authors:  A Dupont; M Vaeth; P Videbech
Journal:  J Ment Defic Res       Date:  1986-06
View more
  29 in total

Review 1.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

Review 2.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

Review 3.  Stem and progenitor cell dysfunction in human trisomies.

Authors:  Binbin Liu; Sarah Filippi; Anindita Roy; Irene Roberts
Journal:  EMBO Rep       Date:  2014-12-17       Impact factor: 8.807

Review 4.  Down syndrome, beta-amyloid and neuroimaging.

Authors:  Elizabeth Head; Alex M Helman; David Powell; Frederick A Schmitt
Journal:  Free Radic Biol Med       Date:  2017-09-19       Impact factor: 7.376

5.  Down syndrome live births following assisted reproductive technology in Japan: a nationwide survey between 2007 and 2016.

Authors:  Seung Chik Jwa; Akira Namba; Shunsuke Tamaru; Akira Kuwahara; Haruhiko Sago; Osamu Ishihara; Yoshimasa Kamei
Journal:  J Assist Reprod Genet       Date:  2022-05-21       Impact factor: 3.357

Review 6.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

Review 7.  Pharmacological interventions for cognitive decline in people with Down syndrome.

Authors:  Nuala Livingstone; Jennifer Hanratty; Rupert McShane; Geraldine Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

Review 8.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

9.  Low Rates of Preventive Healthcare Service Utilization Among Adolescents and Adults With Down Syndrome.

Authors:  Kristin M Jensen; Elizabeth J Campagna; Elizabeth Juarez-Colunga; Allan V Prochazka; Desmond K Runyan
Journal:  Am J Prev Med       Date:  2020-11-12       Impact factor: 5.043

10.  EUROlinkCAT protocol for a European population-based data linkage study investigating the survival, morbidity and education of children with congenital anomalies.

Authors:  Joan K Morris; Ester Garne; Maria Loane; Ingeborg Barisic; James Densem; Anna Latos-Bieleńska; Amanda Neville; Anna Pierini; Judith Rankin; Anke Rissmann; Hermien de Walle; Joachim Tan; Joanne Emma Given; Hugh Claridge
Journal:  BMJ Open       Date:  2021-06-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.